| Patent application number | Description | Published |
|---|
| 20080271503 | Lock, in Particular for Automotive Doors, Flaps or the Like - A lock comprises a rotary latch ( | 11-06-2008 |
| 20090231430 | Device for Capturing an Image of the External Area of a Vehicle by Means of a Camera - In a device for capturing an image of the external area of a vehicle by means of a camera ( | 09-17-2009 |
| 20100209096 | DEVICE WITH A COVER UNIT TO PROTECT A CAMERA UNIT - A device with a camera unit and an operational procedure for the device, where the device has a lens for taking pictures of the area outside of a motor vehicle and a cover unit that can change by means of a drive from a closed position to an open position and vice versa, where the cover unit covers the lens of the camera unit in the closed position and uncovers the lens in the open position making it possible to take a picture, and where the cover unit has a lens cover that is movable on one side by means of a bearing shaft on the device. | 08-19-2010 |
| 20110114637 | SAFETY SYSTEM HAVING A TANK CLOSURE - A safety system, a tank closure and a method for a keyless access control of a tank closure. The safety system includes a tank closure of a motor vehicle, such that the tank closure can be brought into an unlocked state and into a locked state and being provided with a locking unit for locking a tank opening. The locking unit is able to be moved via a drive between a closed position, in which the tank opening is completely closed, and an open position, in which the tank opening is released, for filling the fuel tank. | 05-19-2011 |
| Patent application number | Description | Published |
|---|
| 20090093412 | METHODS FOR THE MODULATION OF NEOVASCULARIZATION AND/OR THE GROWTH OF COLLATERAL ARTERIES AND/OR OTHER ARTERIES FROM PREEXISTING ARTERIOLAR CONNECTIONS - Described is the modulation of the neovascularization and/or growth of collateral arteries and/or other arteries from preexisting arteriolar connections. Methods are provided for enhancing neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections comprising contacting organs, tissue or cells with a colony stimulating factor (CSF) or a nucleic acid molecule encoding said CSF. Furthermore, the use of a CSF or a nucleic acid molecule encoding said CSF for the preparation of pharmaceutical compositions for enhancing neovascularization and/or collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections is described. Also provided are methods for the treatment of tumors comprising contacting an organ, tissue or cells with an agent which suppresses neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through the inhibition of the biological activity of CSFs. Described is further the use of an agent which suppresses neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through inhibition of the biological activity of CSFs for the preparation of pharmaceutical compositions for the treatment of tumors. | 04-09-2009 |
| 20090093413 | METHODS FOR THE MODULATION OF NEOVASCULARIZATION AND/OR THE GROWTH OF COLLATERAL ARTERIES AND/OR OTHER ARTERIES FROM PREEXISTING ARTERIOLAR CONNECTIONS - Described is the modulation of the neovascularization and/or growth of collateral arteries and/or other arteries from preexisting arteriolar connections. Methods are provided for enhancing neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections comprising contacting organs, tissue or cells with a colony stimulating factor (CSF) or a nucleic acid molecule encoding said CSF. Furthermore, the use of a CSF or a nucleic acid molecule encoding said CSF for the preparation of pharmaceutical compositions for enhancing neovascularization and/or collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections is described. Also provided are methods for the treatment of tumors comprising contacting an organ, tissue or cells with an agent which suppresses neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through the inhibition of the biological activity of CSFs. Described is further the use of an agent which suppresses neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through inhibition of the biological activity of CSFs for the preparation of pharmaceutical compositions for the treatment of tumors. | 04-09-2009 |
| 20090191146 | METHODS FOR THE MODULATION OF NEOVASCULARIZATION AND/OR THE GROWTH OF COLLATERAL ARTERIES AND/OR OTHER ARTERIES FROM PREEXISTING ARTERIOLAR CONNECTIONS - Described is the modulation of the neovascularization and/or growth of collateral arteries and/or other arteries from preexisting arteriolar connections. Methods are provided for enhancing neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections comprising contacting organs, tissue or cells with a colony stimulating factor (CSF) or a nucleic acid molecule encoding said CSF. Furthermore, the use of a CSF or a nucleic acid molecule encoding said CSF for the preparation of pharmaceutical compositions for enhancing neovascularization and/or collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections is described. Also provided are methods for the treatment of tumors comprising contacting an organ, tissue or cells with an agent which suppresses neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through the inhibition of the biological activity of CSFs. Described is further the use of an agent which suppresses neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through inhibition of the biological activity of CSFs for the preparation of pharmaceutical compositions for the treatment of tumors. | 07-30-2009 |
| Patent application number | Description | Published |
|---|
| 20090252721 | Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer - The invention relates to agents and methods for the diagnosis, prognosis and treatment of cancer. Specifically, the invention relates to the use of nucleic and amino acid sequences encoding transmembrane superfamily member 6 (TM4SF6), synaptophysin like protein (SYPL), stomatin like 2 (STOML2), Ras related GTP binding protein RAGA), nucleotide sensitive chloride channel 1A (CLNS1A), prion protein (p27-30) (PRNP), guanine nucleotide binding protein beta 2-like 1 (GNB2L1), guanine nucleotide binding protein 4 (GNG4), integral membrane protein 2B (ITM2B), integral membrane protein 1 (ITM1), transmembrane 9 superfamily member 2 (TM9SF2), opiate receptor-like 1 protein (OPRL1), low density lipoprotein receptor-related protein 4 (LRP4), human glomerular epithelial protein 1 (GLEPP1), toll-like receptor 3 (TLR3), and/or zona pellucida glycoprotein 3A (ZP3) for the diagnosis of both early and late stage non-steroid specific cancers, cancer prognosis, as well as screening for therapeutic agents that regulate the gene expression and/or biological activity of said proteins. This invention further relates to the biological technologies designed to inhibit the gene expression and/or biological activity of said proteins including using agents identified in screening assays described herein, vector delivery of antisense polynucleotide sequences, and antibody targeting of said proteins. In specific embodiments, the proteins are of human origin. | 10-08-2009 |
| Patent application number | Description | Published |
|---|
| 20090088216 | User attachable keypad - A wireless communication terminal with a conventional keypad can be provided with a user exchangeable keypad. The wireless communication terminal and user exchangeable cover interface electrically, mechanically or via RF. The user exchangeable keypad can be part of a user exchangeable cover or part of a casing for receiving the wireless terminal. The user exchangeable keypad may have a reduced or adapted set of keys for e.g. facilitating the use of the terminal under special conditions or for visually impaired users. The user exchangeable keypad may be provided with identification means that allow the wireless terminal to identify the user exchangeable keypad and change its setting accordingly by e.g. increasing the font of the text on the display of the wireless terminal. | 04-02-2009 |
| 20090325652 | Cover - A user replaceable cover for a flip part of an apparatus, such as a mobile cellular telephone. The user replaceable cover may overlie a display on the exterior of the flip part of the phone. The display is not visible through the cover in ambient lighting. However, when the display is activated the content of the display is visible through the cover. | 12-31-2009 |
| 20100216518 | FOLDABLE MOBILE COMMUNICATION DEVICE - In accordance with an example embodiment of the present invention, an apparatus comprises a joint which is configured to pivotably couple two housings of the apparatus and comprises a visual indicator; and a controller which is configured to control the visual indicator. | 08-26-2010 |
| 20110143084 | Cover - A user replaceable cover for attachment to and detachment from an apparatus including a first lateral part extending in a first direction, a second lateral part disposed opposite the first lateral part and extending in the first direction, a posterior part extending substantially in a second direction orthogonal to the first direction and joining the first lateral part and the second lateral part and an upper part having extremities and joining at the extremities the first lateral part, the second lateral part and the posterior part, wherein each of the first lateral part, the second lateral part, the posterior part and the upper part has an interior surface and an exterior surface, the user replaceable cover further including a plurality of sidewalls defined by the first lateral part, the second lateral part and the posterior part, wherein the sidewalls terminate at a lower edge for abutment with the apparatus; a face defined by the exterior surface of the upper part; an anterior edge defined at where the first lateral part, the second lateral part and the upper part terminate for abutment with the apparatus; a first posterior tenon extending from the interior surface of the posterior part; a second posterior tenon extending from the interior surface of the posterior part; and an anterior tenon extending from the anterior edge of the first lateral part. | 06-16-2011 |
| 20110168590 | Cover - A cover for an apparatus including a substrate defining the cover and having an exterior surface; a layer over the exterior surface of the substrate; a first portion of the substrate, underlying the layer, having a first composition and defining a first portion of the cover; a second portion of the substrate, underlying the layer, having a second composition and defining a second portion of the cover; wherein the first portion of the cover and the second portion of the cover are substantially opaque in exterior ambient lighting and the second portion of the cover is translucent to backlighting. | 07-14-2011 |
| 20110255216 | Locking Mechanism - An apparatus including a body part configured to receive a replaceable internal part, a first cover part configured to be movable between an open position and a closed position, a second cover part configured to be movable between an open position and a closed position, and when in said closed position, to cover the replaceable internal part. A locking mechanism is configured to lock the second cover part to the body part and the locking mechanism is configured to be releasable, when the first cover part is in said open position and the locking mechanism is configured to be unreleasable, when the first cover part is in said closed position. | 10-20-2011 |
